INFLUENCE OF STORAGE ON HEMOSTATIC PROPERTIES OF PLATELETS FOR TRANSFUSION USE
EHA Library, Carmen Tartari, 145376
ETV6 RELATED THROMBOCYTOPENIA (ETV6RT): A NEW FORM OF INHERITED THROMBOCYTOPENIA (IT) PREDISPOSING TO CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
EHA Library, Federica Melazzini, 145375
PROGNOSTIC ASSESSMENT IN MYH9-RELATED DISEASE: NO LONGER JUST A MATTER OF HEAD OR TAIL
EHA Library, Carlo Zaninetti, 145374
ROMIPLOSTIM IN SPLENECTOMIZED (SPLNX) AND NONSPLENECTOMIZED (NONSPLNX) PATIENTS WITH IMMUNE THROMBOCYTOPENIA (ITP)
EHA Library, Douglas B Cines, 145373
MOLECULAR CHARACTERIZATION OF GLANZMANN'S THROMBASTHENIA IN IRAN: IDENTIFICATION OF THREE NOVEL MUTATIONS
EHA Library, Shima Kazemzadeh, 145372
Strategies to apply recent data in CLL and MCL into clinical practice
EHA Library, Delivered by Janssen, 142525
Strategies to apply recent data in AML and MDS into clinical practice
EHA Library, Delivered by Janssen, 137865
Strategies to apply recent data in multiple myeloma into clinical practice
EHA Library, Delivered by Janssen, 137864
The role of direct oral anticoagulants in 2016
EHA Library, Paul Kyrle, 137118
Causes and consequences of microRNA dysregulation in cancer
EHA Library, Carlo M. Croce, 137117
Clonal evolution of MDS
EHA Library, Benjamin Ebert, 137116
Do we really need new drugs for PV and ET? NO
EHA Library, Carlos Besses, 137110
THE ANTI C1S COMPLEMENT ANTIBODY TNT009 INDUCES RAPID COMPLETE REMISSIONS OF ANAEMIA IN PATIENTS WITH PRIMARY COLD AGGLUTININ DISEASE
EHA Library, Ulrich Jäger, 135348
Do we really need new drugs for PV and ET? YES
EHA Library, Haifa Kathrin Al-Ali, 137109
PHASE 3 RANDOMISED CONTROLLED STUDY OF DARATUMUMAB, BORTEZOMIB AND DEXAMETHASONE VERSUS BORTEZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA: CASTOR
EHA Library, Antonio Palumbo, 135347
Do we really need new diagnostic criteria for MPNs? NO
EHA Library, Jean-Jacques Kiladjian, 137108
Platelets from HIV+ HAART-treated patients contain infectious virus and interact with macrophages
EHA Library, Fernando Real, 135346
Do we really need new diagnostic criteria for MPNs? YES
EHA Library, Tiziano Barbui, 137107
PLATELET TRANSFUSION IN CEREBRAL HAEMORRHAGE (PATCH): A RANDOMISED CONTROLLED TRIAL
EHA Library, Maria Koopman, 135345
OVERALL SURVIVAL IN RELAPSED/REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS RECEIVING INOTUZUMAB OZOGAMICIN VS STANDARD CARE IN THE PHASE 3 INO-VATE STUDY
EHA Library, H Kantarjian, 135344
How to sequence novel agents in Myeloma
EHA Library, Hartmut Goldschmidt, 137098
Challenges for red blood cell biomarker discovery through proteomics
EHA Library, Monique Slijper, 137102
How will monoclonal antibodies change therapy
EHA Library, Philippe Moreau, 137097
Hemolysis and its consequences
EHA Library, Dominik Schaer, 137101
Minimal residual disease including imaging
EHA Library, Bruno Paiva, 137096
Hypomethylating agents in MDS
EHA Library, Valeria SANTINI, 136673
Standard treatment for lower-risk MDS - Where do we stand?
EHA Library, Eva Hellström- Lindberg, 136672
Clinical implications of gene mutations in MDS
EHA Library, Rafael Bejar, 136671
Progress in treatment of ALL in adults
EHA Library, Nicola Gökbuget, 136670
New technologies for MRD in ALL- challenges and opportunities
EHA Library, Jaques J. M. van Dongen, 136669
The role of non-coding DNA in the pathogenesis of T-ALL
EHA Library, Marc Mansour, 136668
JAK inhibitors in MF and PV
EHA Library, Haifa Kathrin Al-Ali, 136667
Mutations and their clinical implications
EHA Library, Paola Guglielmelli, 136666
Role of CALR and its deregulation in MPN
EHA Library, Thorsten Klampfl, 136665
Who should be transplanted in the molecular era?
EHA Library, Richard Schlenk, 136664
Targeting mutant IDH
EHA Library, Eytan Stein, 136663
Dissecting genetic and phenotypic heterogeneity to deliver personalized predictions in AML patients
EHA Library, Elli Papaemmanuil, 136662
Management of MCL in the era of targeted drugs
EHA Library, Tadeusz Robak, 136661
Risk-stratification therapy in MCL
EHA Library, Emmanuelle Zucca, 136660
Sickle cell disease and red cell volume
EHA Library, John Gibson, 137100
Predicting disease behavior in MM - Molecular risk factors and the road to stratified medicine
EHA Library, Martin Kaiser, 137095
Molecular pathogenesis of MCL
EHA Library, German Ott, 136659
SUPER-ENHANCER ANALYSIS DEFINES NOVEL AML AND MDS SUB-TYPES SENSITIVE TO SY-1425, A POTENT AND SELECTIVE RARA AGONIST
EHA Library, Michael McKeown, 135301
LOW-DOSE CHEMOTHERAPY FOLLOWED BY ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR (CAR) T CELLS INDUCES REMISSIONS IN PATIENTS WITH ADVANCED LYMPHOMA
EHA Library, Stephanie Goff, 135286
RESULTS FROM ONGOING PHASE 2 REGISTRATION STUDY OF SL-401 IN PATIENTS WITH BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM (BPDCN)
EHA Library, Naveen Pemmaraju, 135306
PHASE 1B STUDY OF PEMBROLIZUMAB IN PATIENTS WITH RELAPSED/REFRACTORY PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA: KEYNOTE-013
EHA Library, Pier Luigi Zinzani, 135291
BET INHIBITOR AS A NOVEL THERAPEUTIC APPROACH FOR THE TREATMENT OF MLL-REARRANGED INFANT ACUTE LEUKEMIA
EHA Library, Michela Bardini, 135296
BENEFIT OF RITUXIMAB AS SECOND LINE TREATMENT CHOICE FOR AUTOIMMUNE HEMOLYTIC ANEMIA IN CHILDREN : A PROSPECTIVE FRENCH COHORT.
EHA Library, Stéphane Ducassou, 135331
CARDIAC UPTAKE IN AL AMYLOIDOSIS OF 99MTC-DPD AS A NOVEL MARKER OF POOR PROGNOSIS IN SYSTEMIC AL AMYLOIDOSIS
EHA Library, Jiexin ZHENG, 135311
DONOR AND RECIPIENT TOLL-LIKE RECEPTOR 1 VARIATIONS COMPARABLY PREDICT TRANSPLANT-RELATED MORTALITY AFTER UNRELATED BONE MARROW TRANSPLANTATION.
EHA Library, Kaori Uchino, 135316
QUANTIFICATION OF IGG ANTI-ADAMTS13 ANTIBODY LEVEL CAN PREDICT THE LIKELIHOOD OF MORTALITY IN ACUTE THROMBOTIC THROMBOCYTOPENIC PURPURA
EHA Library, Ferras Alwan, 135321
SUCCESSFUL HEMATOPOIETIC STEM CELL TRANSPLANTATION IN TEN PATIENTS WITH SEVERE CONGENITAL NEUTROPENIA USING AN INTENSIVE IMMUNOMYELOSUPPRESSIVE CONDITIONING REGIMEN: THE RESULTS OF A SINGLE INSTITUTE
EHA Library, Yoko Mizoguchi, 135326
HAPLO-IDENTICAL TRANSPLANTATION FOR ACQUIRED SEVERE APLASTIC ANEMIA IN A MULTI-CENTER PROSPECTIVE STUDY
EHA Library, Zhengli Xu, 135325
LONG-TERM RISK OF CARDIOVASCULAR EVENTS FOLLOWING SPLENECTOMY ? A DANISH POPULATION-BASED COHORT STUDY
EHA Library, Marianne Rørholt, 135320
COMPARISON OF OUTCOMES AFTER SINGLE OR DOUBLE UNIT UCBT FOLLOWING RIC IN ADULTS WITH ACUTE LEUKEMIA: A REPORT FROM EUROCORD, THE ALWP & THE CORD BLOOD COMMITTEE OF THE CTIWP OF THE EBMT
EHA Library, Frederic Baron, 135315
UPDATED RESULTS FROM ZUMA-1: A PHASE 1-2 MULTICENTER STUDY EVALUATING THE SAFETY AND EFFICACY OF KTE-C19 (ANTI-CD19 CAR T CELLS) IN REFRACTORY AGGRESSIVE B-CELL NON-HODGKIN LYMPHOMA (NHL)
EHA Library, Tanya Siddiqi, 135285
LUSPATERCEPT DECREASES TRANSFUSION BURDEN AND LIVER IRON CONCENTRATION IN REGULARLY TRANSFUSED ADULTS WITH BETA-THALASSEMIA
EHA Library, Antonio Piga, 135330
DELETION OF CDKN2C DRIVES THE PROGNOSTIC IMPACT OF DELETION 1P IN MULTIPLE MYELOMA
EHA Library, Martin Kaiser, 135310
ACTIVATED JAK-STAT SIGNALING COOPERATES WITH HOXA9 AND DRIVES LEUKEMIA DEVELOPMENT
EHA Library, Charles de Bock, 135295
GPR56 CONTRIBUTES TO THE DEVELOPMENT OF ACUTE MYELOID LEUKEMIA IN MICE
EHA Library, Nicole Kirsten, 135300
ALLOGENEIC STEM CELL TRANSPLANTATION AND BRENTUXIMAB VEDOTIN IN RELAPSED/REFRACTORY HODGKIN LYMPHOMA: A MULTICENTER EXPERIENCE
EHA Library, Moreno Benedetto Festuccia, 135290
RESPONSE-ADAPTED SEQUENTIAL AZACITIDINE AND INDUCTION CHEMOTHERAPY IN PATIENTS > 60 YEARS OLD WITH NEWLY DIAGNOSED AML ELIGIBLE FOR CHEMOTHERAPY (RAS-AZIC): INTERIM ANALYSIS OF THE DRKS00004519 STUDY
EHA Library, Nadja Jaekel, 135305
INTRODUCTION OF A PREOPERATIVE ANAEMIA CLINIC IMPROVES PERI-OPERATIVE TRANSFUSION USE
EHA Library, Ruzaika Cader, 135329
HAPLOTRANSPLANTS VERSUS HLA-IDENTICAL DONOR (HID) FOR ALLOGENEIC STEM-CELL TRANSPLANTATION (ALLOSCT) IN REFRACTORY NON-HODGKIN LYMPHOMA (NHL)
EHA Library, Haiwen Huang, 135284
VERY LATE RELAPSE >5 YEARS AFTER FIRST DIAGNOSIS OF HODGKIN LYMPHOMA: AN ANALYSIS OF THE GERMAN HODGKIN STUDY GROUP HD7-HD12 TRIALS
EHA Library, Paul Bröckelmann, 135289
PRECLINICAL PHARMACOKINETICS AND PHARMACODYNAMICS OF AG-519, AN ALLOSTERIC PYRUVATE KINASE-R ACTIVATOR
EHA Library, Hua Yang, 135324
FAST GENERATION OF CONDITIONAL ROSA26-BASED MOUSE MODELS THAT RECAPITULATE GENOMIC EVENTS IN HUMAN T-ALL
EHA Library, Tim Pieters, 135294
AGONISTIC TARGETING OF TLR1/TLR2 FORCES ACUTE MYELOID LEUKEMIA CELLS INTO DIFFERENTIATION
EHA Library, Mia Eriksson, 135299
NOVEL RARE VARIANTS IN EXON 4 OF GP6 HAVE LARGE EFFECTS ON GPVI EXPRESSION AND PLATELET FUNCTION
EHA Library, Suthesh Sivapalaratnam, 135319
LONG NON-CODING RNA PROFILING PROVIDES IMPORTANT PROGNOSTIC INFORMATION AND BIOLOGIC INSIGHTS IN YOUNGER PATIENTS WITH CYTOGENETICALLY NORMAL ACUTE MYELOID LEUKEMIA (ALLIANCE/CALGB 8461, 9665, 20202)
EHA Library, Dimitrios PAPAIOANNOU, 135304
A PHASE 2, OPEN-LABEL, MULTICENTER STUDY OF ELOTUZUMAB MONOTHERAPY IN PATIENTS WITH HIGH-RISK SMOLDERING MULTIPLE MYELOMA
EHA Library, Sundar Jagannath, 135309
HIGH EXPRESSION OF THE STEM CELL MARKER GPR56 IS ASSOCIATED WITH AN INCREASED RELAPSE INCIDENCE IN AML AFTER ALLOGENEIC STEM CELL TRANSPLANTATION
EHA Library, Madlen Jentzsch, 135314
REDUCED INTENSITY CONDITIONING (RIC) ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR ADULT DE NOVO ACUTE LYMPHOBLASTIC LEUKEMIA: A PROSPECTIVE STUDY FROM THE UKALL14 TRIAL (ISRCTN 66541317)
EHA Library, Dina Okasha, 135313
PHASE 1 STUDY OF VENETOCLAX MONOTHERAPY FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA
EHA Library, Shaji Kumar, 135308
IMPAIRED FUNCTION OF MESENCHYMAL STEM CELLS FROM IMMUNE THROMBOCYTOPENIA PATIENTS IN INDUCING REGULATORY DENDRITIC CELL DIFFERENTIATION VIA NOTCH2/JAGGED-1 SIGNALLING PATHWAY
EHA Library, Yan Su, 135318
OUTCOME OF PATIENTS WITH REFRACTORY OR RELAPSED AML WITH IDH1 AND IDH2 MUTATIONS AFTER CONVENTIONAL SALVAGE THERAPY: A STUDY OF THE GERMAN-AUSTRIAN AML STUDY GROUP (AMLSG)
EHA Library, Peter Paschka, 135303
CHEMO-GENOMIC INTERROGATION OF PRIMARY ACUTE MYELOID LEUKEMIA WITH BIALLELIC CEBPA MUTATIONS REVEALS RECURRENT CSF3R MUTATIONS AND SUBGROUP SENSITIVITY TO JAK INHIBITORS.
EHA Library, Vincent-Philippe Lavallée, 135298
STAT3 GAIN-OF-FUNCTION MUTATIONS CAUSE AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME LIKE DISEASE BY DYSREGULATING EXPRESSION OF FAS AND BCL2 PROTEINS AND CAN BE THERAPEUTICALLY TARGETED BY BH3 MIMETICS
EHA Library, Ute Fischer, 135323
TRIGGERING THE TCR DEVELOPMENTAL CHECKPOINT ACTIVATES A THERAPEUTICALLY TARGETABLE TUMOR SUPPRESSIVE PATHWAY IN T-CELL LEUKEMIA
EHA Library, Amélie Trinquand, 135293
MULTICOHORT PHASE 2 STUDY OF PEMBROLIZUMAB FOR RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA (R/R CHL): KEYNOTE-087
EHA Library, Robert Chen, 135288
THE USE OF PEGYLATED CARBOXYHEMOGLOBIN BOVINE IN PATIENTS FOR WHOM BLOOD IS NOT AN OPTION
EHA Library, Ronald Jubin, 135328
SUBGROUP ANALYSES OF DIFFUSE LARGE B-CELL LYMPHOMA AND INDOLENT LYMPHOMA COHORTS FROM A PHASE IIA STUDY OF SINGLE-AGENT MOR208 IN PATIENTS WITH RELAPSED OR REFRACTORY NON-HODGKIN'S LYMPHOMA
EHA Library, Wojciech Jurczak, 135283
PRETRANSPLANT ANTI-CCR4 ANTIBODY AGAINST ADULT T CELL LEUKEMIA/LYMPHOMA WAS ASSOCIATED WITH SIGNIFICANTLY INCREASED RISKS OF SEVERE/STEROID-REFRACTORY GVHD, NON-RELAPSE MORTALITY AND OVERALL MORTALITY
EHA Library, Shigeo Fuji, 135312
PLATELET PROPERTIES IN A PATIENT WITH STORMORKEN SYNDROME (STIM1 MUTATION) - ADHESION RECEPTOR LEVELS, CALCIUM HOMEOSTASIS AND PHOSPHATIDYLSERINE EXPOSURE
EHA Library, Katherine Cummins, 135317
RICOLINOSTAT (ACY-1215), THE FIRST SELECTIVE HDAC6 INHIBITOR, COMBINED WITH POMALIDOMIDE AND DEXAMETHASONE SHOWS PROMISING EARLY PHASE 2 RESULTS IN RELAPSED-AND-REFRACTORY MULTIPLE MYELOMA: ACE-MM-102
EHA Library, Noopur Raje, 135307
HIGHER DOSE DAUNORUBICIN APPEARS BENEFICIAL IN PATIENTS HARBOURING A FLT3-ITD MUTATION: UPDATED RESULTS OF THE UK NCRI AML17 TRIAL
EHA Library, Nigel Russell, 135302
MASITINIB FOR THE TREATMENT OF SEVERELY SYMPTOMATIC INDOLENT AND SMOLDERING SYSTEMIC MASTOCYTOSIS: A RANDOMIZED, PLACEBO-CONTROLLED, INTERNATIONAL, PHASE 3 STUDY
EHA Library, Olivier Hermine, 135322
TARGETING CHROMATIN REGULATORS INHIBITS LEUKEMOGENIC GENE EXPRESSION IN NPM1 MUTANT LEUKEMIA
EHA Library, Michael Kühn, 135297
TRANSCRIPTION-COUPLED GENETIC INSTABILITY MARKS ACUTE LYMPHOBLASTIC LEUKEMIA STRUCTURAL VARIATION HOTSPOTS
EHA Library, Merja Heinäniemi, 135292
RED CELL ALLOIMMUNISATION RISK IN PATIENTS WITH DIFFERENT TYPES OF INFECTIONS
EHA Library, Dorothea Evers, 135327
CHECKMATE 205: A PHASE 2 STUDY OF NIVOLUMAB IN PATIENTS WITH CLASSICAL HODGKIN LYMPHOMA FOLLOWING AUTOLOGOUS STEM CELL TRANSPLANTATION AND BRENTUXIMAB VEDOTIN
EHA Library, Anas Younes, 135287
CLINICAL CHARACTERISTICS AND PROGNOSTIC FACTORS OF IMMUNOCOMPROMISED AND NON IMMUNOCOMPROMISED PLASMABLASTIC LYMPHOMA PATIENTS: ANALYSIS OF 135 PATIENTS TREATED IN THE LYSA GROUP
EHA Library, Emmanuelle Tchernonog, 135282
MUTATIONS IN TP53 AND JAK2 GENES ARE ASSOCIATED WITH POOR PROGNOSIS IN PEDIATRIC AND ADULT PATIENTS WITH B-CELL PRECURSOR ALL
EHA Library, Jesús M Hernández-Rivas, 133421
MIR-126 DRIVEN LEUKEMIA: A MURINE MODEL TO UNDERSTAND HUMAN B-ALL PATHOGENESIS
EHA Library, Matteo Maria Naldini, 133420
CAPTURE-BASED NEXT GENERATION SEQUENCING (NGS) IDENTIFIES ALSO RARE IG/TCR REARRANGEMENTS IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS
EHA Library, Orietta Spinelli, 133419
THE ROLE OF CNOT3 AND THE ENTIRE CCR4-NOT COMPLEX IN TUMOR DEVELOPMENT
EHA Library, Carmen Vicente, 133418
INSIGHTS INTO THE MOLECULAR EVOLUTION OF BCR-ABLP190 MEDIATED PRECURSOR B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Franziska Auer, 133417
THE HISTONE DEACETYLASE INHIBITOR GIVINOSTAT (ITF2357) HAS A POTENT ANTI-TUMOR ACTIVITY AGAINST CRLF2 REARRANGED LEUKEMIA
EHA Library, Giovanni Cazzaniga, 133416
UNFAVORABLE PROGNOSTIC VALUE OF BCR-ABL1-LIKE IS INDEPENDENT OF AN INTEGRATED GENETIC RISK SCORE IN PEDIATRIC BCP-ALL
EHA Library, Judith Boer, 133415
IN VIVO ROLE OF ACTIVATION INDUCED CYTIDINE DEAMINASE (AID) EXPRESSION IN THE DEVELOPMENT OF PRECURSOR B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Franziska Auer, 133414

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.



{$cookies-google-tag-manager-description}


Save Settings